FDA issues warning on Calif. mammo center

The U.S. Food and Drug Administration (FDA) has issued a warning regarding quality issues in mammograms taken at an imaging center in Huntington Park, CA.

In a March 10 advisory, the FDA reported that it had become aware of quality problems in mammograms performed at Huntington Radiology between September 9, 2008, and September 9, 2010. The agency said that a review of sample exams performed at the facility discovered poor-quality mammograms with possibly unreliable results.

The FDA went on to say that the facility did not meet the standards of the Mammography Quality Standards Act (MQSA), and as of September 9, 2010, the center was not performing mammography because the American College of Radiology had revoked its accreditation.

Although Huntington Radiology sent letters to patients and referring physicians regarding the problems, the facility has been unable to show the FDA that all patients were successfully notified, the agency said. Therefore, the FDA is recommending that patients who received mammograms at Huntington Radiology during the two-year period take several steps, including talking to their healthcare provider about follow-up mammograms.

More information is available by clicking here.